Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol sedation dose for gastroscope insertion in underweight vs normal-weight young women
ChiCTR2200063625Phase 4Completed
- Sponsor
- Beijing Friendship Hospital
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol in None (2 arms), sponsored by Beijing Friendship Hospital. Primary endpoint: effective dose of propofol for successful gastroscope insertion. Started Sep 2022; status: completed.
02
Drugs
propofol
Beyond the preview
Go deeper on ChiCTR2200063625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063625.